Wiley Bros. Aintree Capital, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Wiley Bros. Aintree Capital, LLC

$12.5 Billion
Q2 2025

A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 23,566 shares of XBI stock, worth $2.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,566

Previous 18,243 29.18%

Holding current value

$2.54 Million

Previous $1.48 Million 32.12%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$69.8 - $85.28 $371,545 - $453,945	5,323 Added 29.18%	23,566 $1.95 Million
Q1 2025 May 15, 2025	SELL	$81.1 - $94.7 $8,434 - $9,848	-104 Reduced 0.57%	18,243 $1.48 Million
Q4 2024 Feb 14, 2025	BUY	$89.81 - $104.0 $1.05 Million - $1.21 Million	11,678 Added 175.11%	18,347 $1.65 Million
Q3 2024 Nov 14, 2024	BUY	$90.87 - $102.43 $66,335 - $74,773	730 Added 12.29%	6,669 $658,000
Q2 2024 Jul 23, 2024	BUY	$82.22 - $94.12 $37,821 - $43,295	460 Added 8.4%	5,939 $550,000
Q4 2023 Jan 08, 2024	BUY	$64.12 - $90.86 $384 - $545	6 Added 0.11%	5,479 $489,000
Q3 2023 Oct 06, 2023	SELL	$71.88 - $85.76 $81,224 - $96,908	-1,130 Reduced 17.11%	5,473 $399,000
Q4 2022 Jan 10, 2023	SELL	$76.72 - $85.66 $7,672 - $8,566	-100 Reduced 1.49%	6,603 $0
Q3 2022 Oct 11, 2022	SELL	$75.06 - $94.9 $10,883 - $13,760	-145 Reduced 2.12%	6,703 $532,000
Q2 2022 Jul 06, 2022	BUY	$62.81 - $96.09 $29,709 - $45,450	473 Added 7.42%	6,848 $509,000
Q1 2022 Apr 11, 2022	SELL	$81.07 - $115.44 $4,053 - $5,772	-50 Reduced 0.78%	6,375 $573,000
Q4 2021 Jan 12, 2022	BUY	$108.77 - $134.15 $54,385 - $67,075	500 Added 8.44%	6,425 $719,000
Q3 2021 Oct 07, 2021	SELL	$118.69 - $138.49 $13,055 - $15,233	-110 Reduced 1.82%	5,925 $745,000
Q2 2021 Jul 12, 2021	BUY	$122.48 - $139.69 $26,945 - $30,731	220 Added 3.78%	6,035 $817,000
Q4 2020 Jan 11, 2021	SELL	$110.36 - $151.14 $24,831 - $34,006	-225 Reduced 3.73%	5,815 $819,000
Q2 2020 Jul 07, 2020	SELL	$73.26 - $114.17 $14,652 - $22,834	-200 Reduced 3.21%	6,040 $676,000
Q3 2019 Oct 10, 2019	BUY	$76.25 - $83.86 $80,825 - $88,891	1,060 Added 20.46%	6,240 $476,000
Q3 2019 Oct 04, 2019	SELL	$76.25 - $83.86 $109,418 - $120,339	-1,435 Reduced 21.69%	5,180 $497,000
Q1 2019 Apr 08, 2019	BUY	N/A	60 Added 0.92%	6,615 $599,000
Q4 2018 Feb 06, 2019	BUY	N/A	6,555 New	6,555 $461,000

Others Institutions Holding XBI

# of Institutions

819

Shares Held

111M

Call Options Held

22.6M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.

Account

Wiley Bros. Aintree Capital, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History